LobbyingDenali Therapeutics lobbying by quarter
Denali Therapeutics DNLI's latest lobbying report covers Q2 2026, at $70K. The four quarters Q4 2025–Q3 2026 total $210K. Its first report covers Q1 2025; the issues it reports most are Health Issues.
Denali TherapeuticsDNLI
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $210K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2025 | $67.5K | 1 |
| Q2 2025 | $67.5K | 1 |
| Q3 2025 | $70K | 1 |
| Q4 2025 | $70K | 1 |
| Q1 2026 | $70K | 1 |
| Q2 2026 | $70K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$345K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
No house or agency named.
Firms it paid
| Firm | ||
|---|---|---|
| Manatt, Phelps, and Phillips | $415K | 6 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/14for Q2 | Manatt, Phelps, and Phillips | $70K |
| 04/06for Q1 | Manatt, Phelps, and Phillips | $70K |
| 01/13for Q4 2025 | Manatt, Phelps, and Phillips | $70K |
| 25/10/15for Q3 2025 | Manatt, Phelps, and Phillips | $70K |
| 25/07/10for Q2 2025 | Manatt, Phelps, and Phillips | $67.5K |
| 25/04/15for Q1 2025 | Manatt, Phelps, and Phillips | $67.5K |
| 25/04/15for Q1 2025 | Manatt, Phelps, and Phillips | $67.5K |
| 25/04/14for Q1 2025 | Manatt, Phelps, and Phillips | Under $5,000 |